News
Sam Altman’s Brain Chip Venture Is Mulling Gene Therapy Approach
The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify brain cells, according to people familiar with the plans who weren’t authorized to speak publicly on the matter.
Sam Altman Reportedly Launch Rival Brain-Chip Startup to Compete With Musk’s Neuralink
The new venture will go head-to-head with Elon Musk’s brain chip startup Neuralink. Altman is reportedly betting that AI can give his chips an edge over existing competitors. OpenAI did not immediately respond to a request for comment from Gizmodo.
OpenAI and its cofounder Sam Altman are preparing to back a company that will compete with Elon Musk’s Neuralink by ...
Merge Labs will compete with Elon Musk’s Neuralink, which is developing computer interface chips designed to be implanted in ...
A recent CNBC interview with the OpenAI CEO shows that tech leaders are changing how they judge AI models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback